Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Sep;73(3):709-711.
doi: 10.1016/j.jhep.2020.05.015. Epub 2020 May 20.

Lack of genetic evidence that fatty liver disease predisposes to COVID-19

Luca Valenti  1 , Oveis Jamialahmadi  2 , Stefano Romeo  3
Affiliations
Comment

Lack of genetic evidence that fatty liver disease predisposes to COVID-19

Luca Valenti et al. J Hepatol. 2020 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest Authors declare that they do not have any conflict of interest relevant to the present study. SR has served as a consultant for AstraZeneca, Celgene, Sanofi, Amgen, Akcea Therapeutics, Camp4, Medacorp, Pfizer in the last 5 years. SR has received research grants from AstraZeneca, Sanofi and Amgen. LV reports having received speaking fees from MSD, Gilead, AlfaSigma, AbbVie, having served as a consultant for: Gilead, Pfizer, Astra Zeneca, Novo Nordisk, Intercept, Diatech Pharmacogenetics, Ionis Pharmaceuticals, and received research grants from: Gilead. Please refer to the accompanying ICMJE disclosure forms for further details.

Comment in

Comment on

References

    1. Ji D., Qin E., Xu J., Zhang D., Cheng G., Wang Y., et al. Non-alcoholic fatty liver diseases in patients with COVID-19: a retrospective study. J Hepatol. 2020;73:451–453. - PMC - PubMed
    1. Richardson S., Hirsch J.S., Narasimhan M., Crawford J.M., McGinn T., Davidson K.W., et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323(20):2052–2059. - PMC - PubMed
    1. Sun J., Aghemo A., Forner A., Valenti L. COVID-19 and liver disease. Liver Int. 2020;40(6):1278–1281. - PubMed
    1. Xu L., Liu J., Lu M., Yang D., Zheng X. Liver injury during highly pathogenic human coronavirus infections. Liver Int. 2020;40(5):998–1004. - PMC - PubMed
    1. Trepo E., Valenti L. Update on NAFLD genetics: from new variants to the clinic. J Hepatol. 2020;72(6):1196–1209. - PubMed